PASTORE, GABIRIA
 Distribuzione geografica
Continente #
EU - Europa 2.010
NA - Nord America 1.471
AS - Asia 932
SA - Sud America 153
AF - Africa 47
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.618
Nazione #
US - Stati Uniti d'America 1.433
RU - Federazione Russa 535
IT - Italia 514
SG - Singapore 285
IE - Irlanda 225
CN - Cina 223
DE - Germania 178
GB - Regno Unito 157
BR - Brasile 117
FI - Finlandia 117
VN - Vietnam 117
HK - Hong Kong 102
FR - Francia 75
SE - Svezia 59
KR - Corea 52
IN - India 44
ZA - Sudafrica 31
NL - Olanda 27
BD - Bangladesh 24
ES - Italia 24
CA - Canada 23
PL - Polonia 19
UA - Ucraina 14
CZ - Repubblica Ceca 12
CH - Svizzera 9
IQ - Iraq 9
UZ - Uzbekistan 9
AR - Argentina 8
AT - Austria 8
MX - Messico 8
CI - Costa d'Avorio 7
IL - Israele 7
JP - Giappone 7
BE - Belgio 6
SA - Arabia Saudita 6
TR - Turchia 6
VE - Venezuela 6
IR - Iran 5
PY - Paraguay 5
GR - Grecia 4
PT - Portogallo 4
TH - Thailandia 4
AL - Albania 3
CL - Cile 3
CO - Colombia 3
EC - Ecuador 3
ID - Indonesia 3
KZ - Kazakistan 3
LT - Lituania 3
NG - Nigeria 3
NP - Nepal 3
PE - Perù 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
JM - Giamaica 2
JO - Giordania 2
MD - Moldavia 2
MY - Malesia 2
NO - Norvegia 2
OM - Oman 2
PH - Filippine 2
PK - Pakistan 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
MT - Malta 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RS - Serbia 1
SR - Suriname 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.618
Città #
Dallas 292
Dublin 224
Singapore 178
Moscow 148
San Jose 125
Ashburn 122
Munich 112
Southend 105
Siena 97
Hong Kong 95
Helsinki 85
Santa Clara 85
Chandler 73
Beijing 56
Hefei 55
Fairfield 54
Florence 53
Los Angeles 52
Seoul 48
Milan 47
New York 47
Rome 45
Ho Chi Minh City 41
Woodbridge 30
Hanoi 28
Johannesburg 28
The Dalles 28
Houston 26
Princeton 21
Lappeenranta 20
Cambridge 19
Frankfurt am Main 19
Lauterbourg 19
Seattle 19
Shanghai 18
Wilmington 18
Dong Ket 17
Ann Arbor 16
Orem 15
São Paulo 15
Chicago 12
Düsseldorf 12
London 12
Buffalo 11
Council Bluffs 11
Fremont 11
Montreal 11
Jacksonville 10
Málaga 10
Turku 10
Bengaluru 9
Mumbai 9
Nuremberg 9
Tashkent 9
Warsaw 9
Amsterdam 8
Denver 8
Messina 8
Poggibonsi 8
Portsmouth 8
Abidjan 7
Atlanta 7
Brno 7
Chennai 7
Madrid 7
Menlo Park 7
Washington 7
Bacoli 6
Boardman 6
Brescia 6
Brooklyn 6
Brussels 6
Guangzhou 6
Naples 6
Phoenix 6
Redondo Beach 6
Toronto 6
Baronissi 5
Bologna 5
Dearborn 5
Gurugram 5
San Diego 5
Tokyo 5
Agliana 4
Barolo 4
Columbus 4
Figline Valdarno 4
Goyang-si 4
Lanciano 4
Olomouc 4
Paris 4
Rio de Janeiro 4
Roccagorga 4
Salerno 4
San Francisco 4
Zurich 4
Athens 3
Baghdad 3
Barquisimeto 3
Brasília 3
Totale 2.993
Nome #
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 356
Type M Resistance to Macrolides Is Due to a Two-Gene Efflux Transport System of the ATP-Binding Cassette (ABC) Superfamily 317
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 292
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 290
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 274
Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies 231
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 227
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 218
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 208
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 192
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 190
Streptococcus pyogenes Φ1207.3 Is a Temperate Bacteriophage Carrying the Macrolide Resistance Gene Pair mef(A)-msr(D) and Capable of Lysogenizing Different Streptococci 188
Spike-Specific memory B cell response in hematopoietic cell transplantation recipients following multiple mRNA-1273 vaccinations: a longitudinal observational study 187
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines. 187
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration 180
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity? 176
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine 175
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 157
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses 156
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 142
Third Sars-CoV-2 vaccine dose: B cell and antibody responses following heterologous and homologous vaccination strategies. 117
Persistence of spike-specific memory B cells and antibodies nine months after two doses of BNT162b2 mRNA vaccine. 113
Longitudinal profiling of spike-specific antibody and B cell responses following mRNA-1273 SARS-CoV-2 vaccination in hematopoietic cell transplantation recipients 100
Machine learning approaches to dissect hybrid and vaccine-induced immunity 15
Unexpectedly competent immune response to SARS-CoV-2 vaccination in Rett syndrome 11
Booster dose reshapes SARS-CoV-2 RBD-specific B cell immunity in people living with HIV 9
Totale 4.708
Categoria #
all - tutte 15.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.456


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 0 0 0 0 34
2021/2022198 10 25 7 6 11 4 14 7 20 12 37 45
2022/2023370 22 46 58 29 25 39 19 26 16 18 52 20
2023/2024520 8 8 45 53 27 128 147 10 16 32 9 37
2024/2025995 48 31 124 55 91 59 78 82 116 43 85 183
2025/20262.200 157 267 281 315 469 64 239 54 93 131 89 41
Totale 4.708